<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/505701EA-1757-4736-A8D4-2674E3A349C2"><gtr:id>505701EA-1757-4736-A8D4-2674E3A349C2</gtr:id><gtr:name>University of Oulu</gtr:name><gtr:address><gtr:line1>P.O. Box 4200</gtr:line1><gtr:line4>Oulu</gtr:line4><gtr:line5>FI-90014</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/74E33A9C-42EE-4045-AB11-9FD3FB27E19E"><gtr:id>74E33A9C-42EE-4045-AB11-9FD3FB27E19E</gtr:id><gtr:name>Peviva AB</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C03225F3-03C3-43C0-BE65-A8A629530193"><gtr:id>C03225F3-03C3-43C0-BE65-A8A629530193</gtr:id><gtr:name>University Medical Ctr Hamburg-Eppendorf</gtr:name><gtr:address><gtr:line1>Martinistrasse 52</gtr:line1><gtr:postCode>D-20246</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/08CA3F14-6340-4310-B68F-4E85B059DEB3"><gtr:id>08CA3F14-6340-4310-B68F-4E85B059DEB3</gtr:id><gtr:name>Echosens</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>School of Clinical Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/505701EA-1757-4736-A8D4-2674E3A349C2"><gtr:id>505701EA-1757-4736-A8D4-2674E3A349C2</gtr:id><gtr:name>University of Oulu</gtr:name><gtr:address><gtr:line1>P.O. Box 4200</gtr:line1><gtr:line4>Oulu</gtr:line4><gtr:line5>FI-90014</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/74E33A9C-42EE-4045-AB11-9FD3FB27E19E"><gtr:id>74E33A9C-42EE-4045-AB11-9FD3FB27E19E</gtr:id><gtr:name>Peviva AB</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C03225F3-03C3-43C0-BE65-A8A629530193"><gtr:id>C03225F3-03C3-43C0-BE65-A8A629530193</gtr:id><gtr:name>University Medical Ctr Hamburg-Eppendorf</gtr:name><gtr:address><gtr:line1>Martinistrasse 52</gtr:line1><gtr:postCode>D-20246</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/08CA3F14-6340-4310-B68F-4E85B059DEB3"><gtr:id>08CA3F14-6340-4310-B68F-4E85B059DEB3</gtr:id><gtr:name>Echosens</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/381A1D80-818E-4243-A93B-02265F6B3B4E"><gtr:id>381A1D80-818E-4243-A93B-02265F6B3B4E</gtr:id><gtr:firstName>Jacqueline</gtr:firstName><gtr:otherNames>Frances</gtr:otherNames><gtr:surname>Price</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C2EAA709-2FAD-4219-8D35-B7FE73739CEC"><gtr:id>C2EAA709-2FAD-4219-8D35-B7FE73739CEC</gtr:id><gtr:firstName>Gerry</gtr:firstName><gtr:otherNames>Francis</gtr:otherNames><gtr:surname>Fowkes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/39A9F765-ABA7-43C4-87D2-18BDBE3ECBA5"><gtr:id>39A9F765-ABA7-43C4-87D2-18BDBE3ECBA5</gtr:id><gtr:firstName>Amanda</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Lee</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3B2E2A6E-DFAD-4CB6-828A-F0B5767FA5CE"><gtr:id>3B2E2A6E-DFAD-4CB6-828A-F0B5767FA5CE</gtr:id><gtr:firstName>Rebecca</gtr:firstName><gtr:surname>Reynolds</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/124FB80B-49B5-4C51-8F13-26CC6CAB0DFB"><gtr:id>124FB80B-49B5-4C51-8F13-26CC6CAB0DFB</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Strachan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6B87AA6F-41D4-401E-B78C-31F55E4B57E9"><gtr:id>6B87AA6F-41D4-401E-B78C-31F55E4B57E9</gtr:id><gtr:firstName>Brian</gtr:firstName><gtr:otherNames>Murray</gtr:otherNames><gtr:surname>Frier</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3F80F013-4083-41DC-A241-BB6959CDACAB"><gtr:id>3F80F013-4083-41DC-A241-BB6959CDACAB</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>J.</gtr:otherNames><gtr:surname>Deary</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500877"><gtr:id>A1B17C17-4BDF-4653-BB56-DBB914891DCB</gtr:id><gtr:title>Inflammation, glucocorticoids and microvascular disease in the aetiology of cognitive impairment in type 2 diabetes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500877</gtr:grantReference><gtr:abstractText>People with adult-onset (type 2) diabetes are at increased risk of developing problems with certain functions of the brain, including memory, attentional and problem-solving abilities. These difficulties can significantly impair the ability of a person to carry out routine daily tasks and can have substantial impact on employment and the lives of family and friends. At its severest level, dementia can develop. The prevalence of type 2 diabetes is set to rise dramatically in the years ahead. Therefore, diabetes-related memory impairment could have substantial future social and economic implications.

The cause of these brain function abnormalities is not understood. A range of risk factors, including damage to small blood vessels, inflammation and/or hormonal imbalances can occur in the brains of people with diabetes and it is proposed that this may be a cause of diabetes-related memory impairment. 

We plan to test the brain function of 1000 people with type 2 diabetes. At the same time we will take photographs of the back of subjects eyes to determine whether or not there is small vessel disease and measure other potential risk factors for memory impairment in a blood sample. By comparing the brain function of people with and without risk factors, important information about the cause of diabetes-related memory problems will be obtained.

Traditionally, memory problems in elderly people have been regarded as irreversible, but with a better understanding of the causes of brain function abnormalities in type 2 diabetes, it should be possible to start to develop strategies to prevent, reverse or ameliorate the problem.</gtr:abstractText><gtr:technicalSummary>People with type 2 diabetes are at increased risk of cognitive impairment and dementia. This is of major concern given the predicted future increase in the prevalence of type 2 diabetes. However, the aetiology of cognitive impairment in people with diabetes is unknown. There are strong theoretical grounds, supported by experimental animal data and observational studies in humans, to suggest that microvascular disease, inflammation and/or dysregulation of the HPA axis are likely to explain a significant proportion of the variation in cognitive function in people with type 2 diabetes and an examination of these potential associations forms the basis of the proposed study. A range of cognitive tests, assessing the major domains of mental function, will be administered to one thousand patients with established type 2 diabetes aged over 60 years, at baseline and again after 4 years. The association between cognitive decline and baseline risk factors will be determined and the independence of any relationship with respect to macrovascular disease (and other risk factors) will be assessed. The cohort will also provide the basis for future cerebral neuroimaging and dynamic HPA axis studies. Traditionally, cognitive decrements in elderly people have been regarded as irreversible, but with a better understanding of the aetiology of cognitive impairment in type 2 diabetes, it should be possible to start to develop preventive and/or therapeutic strategies.</gtr:technicalSummary><gtr:fund><gtr:end>2011-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>444290</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Liver fibrosis/University of Nottingham</gtr:description><gtr:id>76C133ED-D397-40C3-83DF-41CFD874E4C5</gtr:id><gtr:impact>Successful clinical research fellowship with Diabetes UK (2011 to 2014) - this collaborator was co-supervisor for Research Fellow's PhD. Four papers published.</gtr:impact><gtr:outcomeId>3044EEFCF6E-1</gtr:outcomeId><gtr:partnerContribution>Expertise in the measurement of liver fibrosis and development of key research questions addressed in the 4 year follow-up phase of the ET2DS</gtr:partnerContribution><gtr:piContribution>Research led by ET2DS team</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Cardiovascular Science</gtr:department><gtr:description>CORNET consortium</gtr:description><gtr:id>A628C5C4-8CD3-41CB-B2E3-8CCC86C9F292</gtr:id><gtr:impact>Formal agreement to act as replication cohort included in successful grant application to CSO.
Genotyping undertaken on ET2DS samples.
Paper published.</gtr:impact><gtr:outcomeId>dZJZwg7eAYk-1</gtr:outcomeId><gtr:partnerContribution>Co-ordination of collaboration and data analysis</gtr:partnerContribution><gtr:piContribution>Provision of data and materials from ET2DS to this multi-study collaboration on genetic variants influencing plasma cortisol (replication cohort), expertise in interpretation of findings.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NAFLD/Pfizer</gtr:description><gtr:id>D2841B6D-A685-44F7-A5E2-F8253E49B566</gtr:id><gtr:impact>papers published (including Williamson et al Diabetes care 2011;34:1139-44) (Williamson et al QJM 2012;105:425). 
Provided baseline data for prospective study on progressive liver disease in people with type 2 diabetes (further funding now obtained from Diabetes UK via clinical research fellowship). Led to further collaborations with academic hepatologists and Echosens.</gtr:impact><gtr:outcomeId>74DF48FBDF6-1</gtr:outcomeId><gtr:partnerContribution>Financial support for phase two of ET2DS, involving assessment of hepatosteatosis. Support provided by Pfizer for clinical research fellow, ultrasonographer, equipment and consumables.</gtr:partnerContribution><gtr:piContribution>ET2DS study team led this study with financial input from Pfizer.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Cardiovascular Science</gtr:department><gtr:description>Pulse wave analysis/velocity</gtr:description><gtr:id>6ADED201-EFD3-42FE-AFC5-B35FE566BE08</gtr:id><gtr:impact>Paper published (WL Teoh et al. Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Journal of Hypertension)</gtr:impact><gtr:outcomeId>DF5AF7B65B2-1</gtr:outcomeId><gtr:partnerContribution>Expertise and provision of equipment for measurement of pulse wave velocity/analysis in the ET2DS cohort.</gtr:partnerContribution><gtr:piContribution>Research led by ET2DS team</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRS validation of US for heapatosteatosis</gtr:description><gtr:id>DB63956F-FCDF-44F2-89EB-717BB1155CE0</gtr:id><gtr:impact>Paper published (Williamson et al . Clinical radiology 2011;66:434-9)
Provided validation of research technique used in subsequent analyses.</gtr:impact><gtr:outcomeId>514598B46F2-1</gtr:outcomeId><gtr:partnerContribution>Funding provided to undertake magnetic resonance spectroscopy on a subset of ET2DS cohort and validate findings of US for heapatosteatosis grading</gtr:partnerContribution><gtr:piContribution>Study led by ET2DS team</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Peviva AB</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Peviva collaboration - CK18 as a marker of steatohepatitis</gtr:description><gtr:id>5646EF9F-3D39-40E1-8EFE-0185E5A04F28</gtr:id><gtr:impact>Measurement of CK18 on stored plasma samples. Two papers published.</gtr:impact><gtr:outcomeId>NwArGuyJhVq-1</gtr:outcomeId><gtr:partnerContribution>Measurement of CK18, a marker of hepatosteatosis, on stored plasma samples from ET2DS</gtr:partnerContribution><gtr:piContribution>Lead for collaboration. Expertise in epidemiology and use of own dataset/phenotypic data. Provision of samples for biomarker measurement.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Carotid phenotypes collaboration</gtr:description><gtr:id>04D291F5-DF4D-4F69-BFF9-BFE4DA26CEB6</gtr:id><gtr:impact>Establishment of dataset across multiple studies in advance of data analysis. Now incorporated into other collaboration (UCLEB)</gtr:impact><gtr:outcomeId>VpRp2dGcBpY-1</gtr:outcomeId><gtr:partnerContribution>Co-ordination of multi-centre collaboration and primary data analysis</gtr:partnerContribution><gtr:piContribution>Provision of data and expertise on genetic and non-genetic risk factors potentially affecting carotid intima media thickness and plaque</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Renal Medicine Edinburgh</gtr:department><gtr:description>Renal disease in ET2DS</gtr:description><gtr:id>00D4FE86-25A4-4E48-9E6B-E1D9A636D1FD</gtr:id><gtr:impact>Measurement of renal tubular biomarkers in stored urine samples from baseline phase of ET2DS. Paper published in Kidney International (2012), further papers published 2014 and 2016, MD student registered to work on project.</gtr:impact><gtr:outcomeId>pu2N2Y6WFi2-1</gtr:outcomeId><gtr:partnerContribution>Measurement of urinary biomarkers to be assessed as predictors of diabetic nephropathy and expertise in renal medicine</gtr:partnerContribution><gtr:piContribution>Work led jointly with collaborator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Medical Center Hamburg-Eppendorf</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Dimethylarginines and CVD</gtr:description><gtr:id>38380DFD-3EB0-4BB5-B8C8-6452342A2E0F</gtr:id><gtr:impact>Paper published</gtr:impact><gtr:outcomeId>TwecqeHhXWh-1</gtr:outcomeId><gtr:partnerContribution>Measurement of plasma dimethylarginines in ET2DS cohort and expertise in interpretation of findings</gtr:partnerContribution><gtr:piContribution>Co-lead for collaboration. Provision of samples, data and expertise in interpretation of findings</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Interleukin 6 receptor as a potential target for CHD prevention: evaluation using Mendelian randomisation</gtr:description><gtr:id>223DF244-031E-41CB-AC5B-6C590A8C71DE</gtr:id><gtr:impact>Paper published in Lancet (Lancet 2012;379:1214-24)</gtr:impact><gtr:outcomeId>m4qKe8gQHpF-2</gtr:outcomeId><gtr:partnerContribution>Key single nucleotide polymorphisms in the IL-6 receptor gene were measured by our collaborators for the purposes of this project. We are now investigating the role of these SNPs in cognitive impairment as part of our own research, without the need for de novo genotyping.</gtr:partnerContribution><gtr:piContribution>Provision of DNA samples for genotyping, provision of phenotypic data and expertise in interpretation of findings for this multi-centre study</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Clinical Biochemistry</gtr:department><gtr:description>Apolipoproteins, TFTs and steroid sex hormones as predictors of CVD in type 2 diabetes</gtr:description><gtr:id>D936BF25-7456-46D1-8740-C92625B5B597</gtr:id><gtr:impact>Provision of biomarker data on ET2DS cohort over-and-above that funded by original MRC grant. Data analysed as part of successful Masters student project. Data incorporated into publications.</gtr:impact><gtr:outcomeId>9A85DADEFC2-1</gtr:outcomeId><gtr:partnerContribution>Measurement of triglycerides, apolipoproteins, free fatty acids, thyroid function tests and testosterone on ET2DS cohort</gtr:partnerContribution><gtr:piContribution>Research led by ET2DS team</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Cardiovascular and Medical Sciences (ICAMS)</gtr:department><gtr:description>Leptin, pro-BNP and troponin/Glasgow University</gtr:description><gtr:id>558BB825-9BC6-4E06-A1F5-D1B7A3C92C34</gtr:id><gtr:impact>Paper published (PLOS One 2012;7:e44569). Further paper published 2014. PhD student registered to work on project. Further analyses planned 2017 onwards</gtr:impact><gtr:outcomeId>tCoM7rYN2M4-1</gtr:outcomeId><gtr:partnerContribution>Measurement of plasma leptin, N-terminal pro b-type natriuretic peptide and troponin in ET2DS participants and expertise in interpretation of findings</gtr:partnerContribution><gtr:piContribution>Research led jointly with collaborator. Provision of cohort data and samples, expertise in epidemiology, cognition, diabetes and vascular disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Leeds Institute of Genetics, Health and Therapeutics (LIGHT)</gtr:department><gtr:description>Fibrinolysis and CVD/Leeds University</gtr:description><gtr:id>058F3EFD-3E5F-46A8-BE3B-B16FEDC9880A</gtr:id><gtr:impact>Papers published.</gtr:impact><gtr:outcomeId>5B97C1FC68A-1</gtr:outcomeId><gtr:partnerContribution>Measurements of parameters of clotting and fibrinolysis, data analysis, clinical/biochemical expertise in interpretation of findings</gtr:partnerContribution><gtr:piContribution>Co-lead for collaboration. Provision of samples, data and epidemiological expertise in analysis and interpretation of findings</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Echosens</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Transient elastography for liver fibrosis</gtr:description><gtr:id>A955AEF6-517E-4D54-8DEF-7156BF9C09D4</gtr:id><gtr:impact>Contribution to successful clinical research fellowship with Diabetes UK.
Measurement of liver stiffness in large cohort, making major contribution to liver phenotyping in ET2DS database.
Paper published.</gtr:impact><gtr:outcomeId>57D061308E0-1</gtr:outcomeId><gtr:partnerContribution>Provision of Echosens 'Fibroscan' machine and training for ultrasonographer for 4-year follow-up phase of study to enable measurement of liver fibrosis, at no cost to project</gtr:partnerContribution><gtr:piContribution>Research led by ET2DS team</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Epidemiology and Health Care</gtr:department><gtr:description>UCLEB consortium</gtr:description><gtr:id>47E263AF-95E8-405F-ACF6-CAAF657A7CED</gtr:id><gtr:impact>Collaboration has resulted in successful grant applications to BHF (Approx &amp;pound;1M over 5 years from Jan 2011 and approx. &amp;pound;900K over 3 years from Jan 2014) to fund this consortium. Collaboration has resulted in funding for high density genotyping (both 'metabochip' and, in 2016, a high density drug target array) in the ET2DS, as well as metabolomics measurements and data analysis. Genotyping has now been completed and analysis is well underway, with several papers already published and more drafted. A further grant application is planned for 2017.</gtr:impact><gtr:outcomeId>4F76286567E-1</gtr:outcomeId><gtr:partnerContribution>Collaborative analyses of large datasets undertaken as part of consortium of prospective UK-based studies (including ET2DS)</gtr:partnerContribution><gtr:piContribution>ET2DS is one of the major cohorts participating in UCLEB (University College London Edinburgh Bristol consortium of major UK prospective population-based studies: applied and translational genomics).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oulu</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:department>Institute of Clinical Medicine</gtr:department><gtr:description>Metabolomics</gtr:description><gtr:id>A2660FD8-B1BC-4057-B5D7-4F1F79ECB95C</gtr:id><gtr:impact>J Price is co-investigator on BHF grant for further funding for metabolomics work on ET2DS as part of UCLEB consortium. PhD student registered to work on this project within ET2DS.</gtr:impact><gtr:outcomeId>pAWQhEfHfbw-1</gtr:outcomeId><gtr:partnerContribution>Expertise in metabolomic measurements and analysis on samples from ET2DS</gtr:partnerContribution><gtr:piContribution>Lead in collaboration, provision of samples from ET2DS for metabolomic analysis, analysis and expertise in interpretation of findings</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Interleukin 6 receptor as a potential target for CHD prevention: evaluation using Mendelian randomisation</gtr:description><gtr:id>E8097A70-63FC-4ECC-B3DC-9261659427F3</gtr:id><gtr:impact>Paper published in Lancet (Lancet 2012;379:1214-24)</gtr:impact><gtr:outcomeId>m4qKe8gQHpF-1</gtr:outcomeId><gtr:partnerContribution>Key single nucleotide polymorphisms in the IL-6 receptor gene were measured by our collaborators for the purposes of this project. We are now investigating the role of these SNPs in cognitive impairment as part of our own research, without the need for de novo genotyping.</gtr:partnerContribution><gtr:piContribution>Provision of DNA samples for genotyping, provision of phenotypic data and expertise in interpretation of findings for this multi-centre study</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Media release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>BC7883AC-1E1C-4D51-BE48-1771D2527538</gtr:id><gtr:impact>Media release via Diabetes UK to co-incide with presentation (links between hypoglycaemia and cognitive impairment) at their Annual Professional Conference.

Publications in media, including BBC news, and interest from members of public in on-going research</gtr:impact><gtr:outcomeId>91D2585F5BA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to local members of Diabetes UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>13A1018A-91D5-4419-A241-1BE743467336</gtr:id><gtr:impact>This was a presentation on the research into liver disease being performed in the Edinburgh Type 2 Diabetes Study. There were over 50 people with diabetes in the audience; there was considerable interest in the study and numerous questions afterwards.

Increased awareness of non alcoholic fatty liver disease as a complication of type 2 diabetes</gtr:impact><gtr:outcomeId>XkKqA35dvXr</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>B585AB79-8CB4-435E-BA89-807073AC83A3</gtr:id><gtr:impact>Media release prepared on research relating to links between stress and memory

Articles published in national press, including national newspaper and BBC news</gtr:impact><gtr:outcomeId>TuaRZx6DMjT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>122E86CC-0E89-47F6-A55A-907EE30F4C51</gtr:id><gtr:impact>Media release produced to co-incide with presentation of results (links between retinopathy and cognition) at Diabetes UK annual conference

Dissemination on websites for general public and people with type 2 diabetes</gtr:impact><gtr:outcomeId>m64hv8y17oY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to Diabetes UK Patient Group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>F231A425-2EFB-4C6E-A636-2B7C8018E6D9</gtr:id><gtr:impact>This was a presentation on the research being performed in the Edinburgh Type 2 Diabetes Study to the annual meeting of the Edinburgh Branch of Diabetes UK. There were over 50 people with diabetes in the audience; there was considerable interest in the study and numerous questions afterwards.

Increased knowledge of the risks of cognitive impairment and hypoglycaemia in the target patient group.</gtr:impact><gtr:outcomeId>QbqPiixfoq8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>347000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer plc</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>33FCE76E-83D0-401E-B1B1-3F1EF5CAE9C4</gtr:id><gtr:outcomeId>544f7a73b3f282.87282432</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>College of Medicine &amp; Veterinary Medicine</gtr:department><gtr:description>PhD Studentship (College of Medicine, University of Edinburgh) - A Price</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>646CF7E3-4DBC-4D59-8331-0F21B54D07E0</gtr:id><gtr:outcomeId>544f7c80252f22.52024257</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>71656</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK (PhD studentship)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:fundingRef>15/0005353</gtr:fundingRef><gtr:id>5AB913DC-6719-4245-8290-46C61930D294</gtr:id><gtr:outcomeId>56d43fb32804f9.79110815</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship (ESRC allocation to CPHS, University of Edinburgh) - M Keller</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Economic and Social Research Council</gtr:fundingOrg><gtr:id>EE5A455C-73AD-4971-98BA-45B49CB5B716</gtr:id><gtr:outcomeId>Eb82bYHczgb0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>Mexico, United Mexican States</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship (Mexican Council of Science and Technology (CONACyT) allocation to CPHS, University of Edinburgh) - E Sandoval Garcia</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Council on Science and Technology (CONACYT)</gtr:fundingOrg><gtr:id>772126FE-A995-4E5F-BFDD-643C93902684</gtr:id><gtr:outcomeId>544f7dcc8a0b24.74257110</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Scottish Funding Council</gtr:department><gtr:description>PhD Studentship, College of Medicine, University of Edinburgh - J Ding</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Government of Scotland</gtr:fundingOrg><gtr:id>BDB1D647-18C2-4B02-B29F-6DC9F600C97E</gtr:id><gtr:outcomeId>YLkdgR5yVsG0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship (ESRC allocation to CPHS, University of Edinburgh) - I Feinkohl</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Economic and Social Research Council</gtr:fundingOrg><gtr:id>84D0B0BE-760A-4E40-855A-3BF4CFC30599</gtr:id><gtr:outcomeId>tj2Kc9ZaQ7j0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship (MRC allocation to CPHS, University of Edinburgh) - R Marioni</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>952D01C2-D871-47DF-BAEF-380D450ABD0E</gtr:id><gtr:outcomeId>RyWStU62can0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>B00DAD97-3482-4182-AC5A-AD4ED949C0B5</gtr:id><gtr:outcomeId>dfv5JmuF5wG0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>9BECF62F-0120-4468-B3D9-FD4935B0ABB1</gtr:id><gtr:outcomeId>tpVTMg29kt10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>23000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CSO Programme Support Grant</gtr:description><gtr:end>2007-08-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>6BABE610-6815-4D79-AEA7-4B77D976767D</gtr:id><gtr:outcomeId>8ACD6AA6AE80</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship (ESRC allocation to CPHS, University of Edinburgh) - C Robertson</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Economic and Social Research Council</gtr:fundingOrg><gtr:id>4377DC73-2A1D-4752-BA49-F7C4E9005AAD</gtr:id><gtr:outcomeId>AQoCHEm78az0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>41556</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>1FA049F4-9940-4F36-801E-B92043829ABC</gtr:id><gtr:outcomeId>544f7afc79b1c7.70288994</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>A84F7C93-B6F0-46C4-9197-AA395DF51A0C</gtr:id><gtr:outcomeId>ewuPpMuckbT0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre Cognitive Aging and Cognitiove Epidemiology, University Edinburgh (PhD Studentship to A. Suliman)</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0ECCD22E-9B16-4645-9848-4814086CFB72</gtr:id><gtr:outcomeId>56d43f12566bf5.04308044</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Extensive database created for analysis of association between risk factors and complications of type 2 diabetes. High quality DNA, plasma and urine banks created for measurement of additional risk factors.</gtr:description><gtr:id>3F42C9E9-92EA-42EA-8B6C-1381367532F0</gtr:id><gtr:impact>see list of collaborations</gtr:impact><gtr:outcomeId>B8EEF35330A</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ET2DS database, DNA and plasma banks</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>93672CB7-CDA4-431B-B8A6-7D669C3778C0</gtr:id><gtr:title>Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study.</gtr:title><gtr:parentPublicationTitle>Liver international : official journal of the International Association for the Study of the Liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5161c8803a66c22f1413fddae8ebae98"><gtr:id>5161c8803a66c22f1413fddae8ebae98</gtr:id><gtr:otherNames>Morling JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1478-3223</gtr:issn><gtr:outcomeId>pm_12814_24_24237940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D824794-1C28-42F5-B209-3EFB82DF5ACE</gtr:id><gtr:title>A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13ce639a6c9ba49442b31b55d4d37555"><gtr:id>13ce639a6c9ba49442b31b55d4d37555</gtr:id><gtr:otherNames>Hess K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>Ekcj7wZZhNi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D16D2A7-D6E2-4496-8512-30B9CFFB5378</gtr:id><gtr:title>Retinal microvascular abnormalities and cognitive dysfunction: a systematic review.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/494ba6196af3cd99ac66b5a0659118db"><gtr:id>494ba6196af3cd99ac66b5a0659118db</gtr:id><gtr:otherNames>Ding J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>EC72A778490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7C449DA-3CD8-4CDA-8CAD-8898872AE5E8</gtr:id><gtr:title>Cognitive impairment in elderly people with Type 2 diabetes: is there an association and why?</gtr:title><gtr:parentPublicationTitle>Aging Health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8556a921f3a1e77a227ec5250ac7113b"><gtr:id>8556a921f3a1e77a227ec5250ac7113b</gtr:id><gtr:otherNames>Price J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>aqnA2qaRXuG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A185CD3E-8EA9-4F4D-9131-2D2F029BA2D4</gtr:id><gtr:title>Association of retinal arteriolar dilatation with lower verbal memory: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/494ba6196af3cd99ac66b5a0659118db"><gtr:id>494ba6196af3cd99ac66b5a0659118db</gtr:id><gtr:otherNames>Ding J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>Zgp3ApxQJMR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98F3DBCF-D616-4134-86EB-00A695AA5F02</gtr:id><gtr:title>Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45966772f9f56b02fed5080346c3b8b6"><gtr:id>45966772f9f56b02fed5080346c3b8b6</gtr:id><gtr:otherNames>Alzahrani SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_12814_24_22996148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFD3954C-6BB8-414C-A0E2-CAD6321E1E1A</gtr:id><gtr:title>Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b9edc986e1ba4615154efa5d4ee7d99"><gtr:id>7b9edc986e1ba4615154efa5d4ee7d99</gtr:id><gtr:otherNames>Conway BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>pm_12814_24_22718188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E936CD5-C599-451B-9A65-9B39BDB2C5CD</gtr:id><gtr:title>?-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5161c8803a66c22f1413fddae8ebae98"><gtr:id>5161c8803a66c22f1413fddae8ebae98</gtr:id><gtr:otherNames>Morling JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>5524e6174036b8.18876293</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5038218A-40E7-4901-933B-7F223B1E4E29</gtr:id><gtr:title>The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy.</gtr:title><gtr:parentPublicationTitle>Clinical radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ad0505b5e34cb9c9e0ef28546bcbf33"><gtr:id>3ad0505b5e34cb9c9e0ef28546bcbf33</gtr:id><gtr:otherNames>Williamson RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-9260</gtr:issn><gtr:outcomeId>SQ3MmLunAR6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09F5EA7A-2CA7-4D8A-B7A8-C509F6A8E6C2</gtr:id><gtr:title>The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies.</gtr:title><gtr:parentPublicationTitle>Diabetes, obesity &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6c61ecb47cb85b1ce30fe7a5d11610c"><gtr:id>c6c61ecb47cb85b1ce30fe7a5d11610c</gtr:id><gtr:otherNames>Strachan MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1462-8902</gtr:issn><gtr:outcomeId>HgdA4oDZevw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5572B230-8188-490C-A16E-D6DC416E4E46</gtr:id><gtr:title>Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe39d0fd50d4a69849d54adcc4fd46e1"><gtr:id>fe39d0fd50d4a69849d54adcc4fd46e1</gtr:id><gtr:otherNames>Reynolds RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>EECC801F652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A28F463-C521-4A3E-885A-3D4CAFFDDB01</gtr:id><gtr:title>Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53d43057b337fd8e952686dbe2374bc2"><gtr:id>53d43057b337fd8e952686dbe2374bc2</gtr:id><gtr:otherNames>Anderssohn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>pm_12814_24_24186881</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07DFC9AF-B94C-4A33-8317-41D30B58405C</gtr:id><gtr:title>Variation in the uric acid transporter gene (SLC2A9) and memory performance.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b9aee8223f9cfab1a5d8f96af8c1769"><gtr:id>5b9aee8223f9cfab1a5d8f96af8c1769</gtr:id><gtr:otherNames>Houlihan LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>et3zwa1NoHK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47775B3C-14EE-4024-88B9-D879ECF2C183</gtr:id><gtr:title>Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5161c8803a66c22f1413fddae8ebae98"><gtr:id>5161c8803a66c22f1413fddae8ebae98</gtr:id><gtr:otherNames>Morling JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>56275a8a3a9200.20413295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CF67BBD-E6B8-44EF-9A94-A28D567B182C</gtr:id><gtr:title>N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0b0d894ef807f1af6ae0b393015d3fe"><gtr:id>b0b0d894ef807f1af6ae0b393015d3fe</gtr:id><gtr:otherNames>Price AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>5423dba6846f03.74201896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E60A0A0-ACF0-4371-9125-DAFFE7DD8DC2</gtr:id><gtr:title>Replication and Characterization of Association between ABO SNPs and Red Blood Cell Traits by Meta-Analysis in Europeans.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/896aaf1ab3ce6e92144b66a611748946"><gtr:id>896aaf1ab3ce6e92144b66a611748946</gtr:id><gtr:otherNames>McLachlan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>578c95ead35676.64944581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA23B3B1-66A8-4438-9718-78817F20A1EE</gtr:id><gtr:title>Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9e732e9b163bed88e297f52d9a20382"><gtr:id>f9e732e9b163bed88e297f52d9a20382</gtr:id><gtr:otherNames>Fairoozy RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>5a34f2ec5173c4.65452645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2349AD60-213D-440B-86C9-C23A55BAC558</gtr:id><gtr:title>Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ad756a05d24b86ee8a1edc56a7012aa"><gtr:id>4ad756a05d24b86ee8a1edc56a7012aa</gtr:id><gtr:otherNames>Feinkohl I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>pm_12814_24_24103900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6952633A-4D35-4D8C-A511-536CB8CFA33B</gtr:id><gtr:title>B?Arg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/698e93368c6e320174f094b8fdee9201"><gtr:id>698e93368c6e320174f094b8fdee9201</gtr:id><gtr:otherNames>Greenhalgh KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>585114dfe70860.74974950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E548DF20-C523-43FE-A2F2-6F5701FA64E1</gtr:id><gtr:title>Mendelian Randomisation study of the influence of eGFR on coronary heart disease.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31eaf745f45121255e6739557766d11f"><gtr:id>31eaf745f45121255e6739557766d11f</gtr:id><gtr:otherNames>Charoen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>578c959e5d39d3.24085757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCB74780-035C-4B7D-8208-700E6155E94F</gtr:id><gtr:title>Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63715e8253a1025b75b6da1e05bfd0f2"><gtr:id>63715e8253a1025b75b6da1e05bfd0f2</gtr:id><gtr:otherNames>Bedenis R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>5423dbfd30ae88.96838647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35BFA32A-5D68-4A14-A0FC-9DB3488BC878</gtr:id><gtr:title>Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe39d0fd50d4a69849d54adcc4fd46e1"><gtr:id>fe39d0fd50d4a69849d54adcc4fd46e1</gtr:id><gtr:otherNames>Reynolds RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5686752D10D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB4913B8-FE9C-4480-B193-8A1335417845</gtr:id><gtr:title>Leptin levels and depressive symptoms in people with type 2 diabetes: the edinburgh type 2 diabetes study.</gtr:title><gtr:parentPublicationTitle>Psychosomatic medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee011dfb51cc6b6d114a37b44f1ec757"><gtr:id>ee011dfb51cc6b6d114a37b44f1ec757</gtr:id><gtr:otherNames>Labad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0033-3174</gtr:issn><gtr:outcomeId>RQcYrc95ThS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1154F19E-054E-467D-AB1B-726F015C4872</gtr:id><gtr:title>Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5161c8803a66c22f1413fddae8ebae98"><gtr:id>5161c8803a66c22f1413fddae8ebae98</gtr:id><gtr:otherNames>Morling JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>pm_12814_24_24512822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7D88BAB-8542-4E0F-ACE7-C206BDCF3683</gtr:id><gtr:title>Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13ce639a6c9ba49442b31b55d4d37555"><gtr:id>13ce639a6c9ba49442b31b55d4d37555</gtr:id><gtr:otherNames>Hess K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_12814_24_24838681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>179AE52C-4049-4B9F-A86B-5D6E4C38BF1B</gtr:id><gtr:title>Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ad0505b5e34cb9c9e0ef28546bcbf33"><gtr:id>3ad0505b5e34cb9c9e0ef28546bcbf33</gtr:id><gtr:otherNames>Williamson RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>WJHT4bKYUKo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCAF3C13-3FD0-465C-B56F-40C3956DA865</gtr:id><gtr:title>Serum leptin and cognitive function in people with type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee011dfb51cc6b6d114a37b44f1ec757"><gtr:id>ee011dfb51cc6b6d114a37b44f1ec757</gtr:id><gtr:otherNames>Labad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12814_24_22475620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D179DFE9-C2ED-4704-B669-A03660AA1E71</gtr:id><gtr:title>Functional Analysis of the Coronary Heart Disease Risk Locus on Chromosome 21q22.</gtr:title><gtr:parentPublicationTitle>Disease markers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b02f344b939b517cc635f6f7423dd028"><gtr:id>b02f344b939b517cc635f6f7423dd028</gtr:id><gtr:otherNames>Beaney KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0278-0240</gtr:issn><gtr:outcomeId>5a34f2e22c45d2.67143966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A3C7C91-C65A-4B45-9CB7-84E1861DADBE</gtr:id><gtr:title>The Edinburgh Type 2 Diabetes Study: study protocol.</gtr:title><gtr:parentPublicationTitle>BMC endocrine disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7af801a5159c73b0fbb34dd43ebac34"><gtr:id>c7af801a5159c73b0fbb34dd43ebac34</gtr:id><gtr:otherNames>Price JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1472-6823</gtr:issn><gtr:outcomeId>A55F1A3D8FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CA1B5CE-EABF-4709-8799-AD6329303B1E</gtr:id><gtr:title>Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe39d0fd50d4a69849d54adcc4fd46e1"><gtr:id>fe39d0fd50d4a69849d54adcc4fd46e1</gtr:id><gtr:otherNames>Reynolds RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>pm_12814_24_22408122</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C610509-7F77-4088-89BE-17849741DA4D</gtr:id><gtr:title>Diabetes. Cognitive decline and T2DM--a disconnect in the evidence?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6c61ecb47cb85b1ce30fe7a5d11610c"><gtr:id>c6c61ecb47cb85b1ce30fe7a5d11610c</gtr:id><gtr:otherNames>Strachan MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-5029</gtr:issn><gtr:outcomeId>pm_12814_24_24686200</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93CD9A22-E73D-44FC-B879-D30830481DC1</gtr:id><gtr:title>Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a06bcb25009e3fface332b51a9c2bf7b"><gtr:id>a06bcb25009e3fface332b51a9c2bf7b</gtr:id><gtr:otherNames>Shah T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12814_24_23977022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77909DAC-75E8-46E9-B7B3-B76C4C805390</gtr:id><gtr:title>Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ad756a05d24b86ee8a1edc56a7012aa"><gtr:id>4ad756a05d24b86ee8a1edc56a7012aa</gtr:id><gtr:otherNames>Feinkohl I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12814_24_22973461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17ACCA48-E69D-49CD-AD78-515DF4FD9D1C</gtr:id><gtr:title>Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f435dec7cdc4fd944a02c459b769cd83"><gtr:id>f435dec7cdc4fd944a02c459b769cd83</gtr:id><gtr:otherNames>White J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>56a0c03528dea8.83989368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54C422AE-FCD5-4507-B2F8-3719D25D424D</gtr:id><gtr:title>Blood rheology and cognition in the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Age and ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92c807dd74c086f13d2174d70fc9bf1c"><gtr:id>92c807dd74c086f13d2174d70fc9bf1c</gtr:id><gtr:otherNames>Marioni RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-0729</gtr:issn><gtr:outcomeId>C60BB37F062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7FD19C4-D399-42CD-AFDC-689203C13785</gtr:id><gtr:title>Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts.</gtr:title><gtr:parentPublicationTitle>Behavior genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92c807dd74c086f13d2174d70fc9bf1c"><gtr:id>92c807dd74c086f13d2174d70fc9bf1c</gtr:id><gtr:otherNames>Marioni RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-8244</gtr:issn><gtr:outcomeId>qHszY6UtTL5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EE6EBE6-74FC-4B18-A36D-9DF045083547</gtr:id><gtr:title>Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ad756a05d24b86ee8a1edc56a7012aa"><gtr:id>4ad756a05d24b86ee8a1edc56a7012aa</gtr:id><gtr:otherNames>Feinkohl I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>pm_12814_24_23579182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20CE95F1-3A99-4B3A-B4CC-2B48003764CD</gtr:id><gtr:title>The relationship between type 2 diabetes and dementia.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6c61ecb47cb85b1ce30fe7a5d11610c"><gtr:id>c6c61ecb47cb85b1ce30fe7a5d11610c</gtr:id><gtr:otherNames>Strachan MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>XhD2gJoieZn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C97914C-19DE-4744-B786-7C3C1127F9C6</gtr:id><gtr:title>Cognitive function, dementia and type 2 diabetes mellitus in the elderly.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6c61ecb47cb85b1ce30fe7a5d11610c"><gtr:id>c6c61ecb47cb85b1ce30fe7a5d11610c</gtr:id><gtr:otherNames>Strachan MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1759-5029</gtr:issn><gtr:outcomeId>HAYgWcPTejx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>444AA607-39A2-42D7-A24E-C74E4783869C</gtr:id><gtr:title>HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfd6719eeaadb3d2f606c3b93066661d"><gtr:id>cfd6719eeaadb3d2f606c3b93066661d</gtr:id><gtr:otherNames>Swerdlow DI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54350506e9b970.98140284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6FE3C8B-FD9F-4A90-A81D-8ACBA40B3A01</gtr:id><gtr:title>The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8298237a0c7e333d8706a08172781a8f"><gtr:id>8298237a0c7e333d8706a08172781a8f</gtr:id><gtr:otherNames>Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_12814_24_22421340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5AE48B8-5235-4474-ADBA-119D5D29B538</gtr:id><gtr:title>Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids.</gtr:title><gtr:parentPublicationTitle>Cardiovascular diabetology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b02f344b939b517cc635f6f7423dd028"><gtr:id>b02f344b939b517cc635f6f7423dd028</gtr:id><gtr:otherNames>Beaney KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2840</gtr:issn><gtr:outcomeId>57c7f4245283c2.81769958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CC91844-B2F6-4933-9CFF-B420F13C82FA</gtr:id><gtr:title>Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ad756a05d24b86ee8a1edc56a7012aa"><gtr:id>4ad756a05d24b86ee8a1edc56a7012aa</gtr:id><gtr:otherNames>Feinkohl I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>552cf3d457c985.25394471</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2796A394-26AC-4321-9E87-1FFCF4AC6B23</gtr:id><gtr:title>Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes: the Edinburgh Type 2 diabetes study.</gtr:title><gtr:parentPublicationTitle>Journal of hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/512d07b2a824d997118b709c669bf79b"><gtr:id>512d07b2a824d997118b709c669bf79b</gtr:id><gtr:otherNames>Teoh WL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0263-6352</gtr:issn><gtr:outcomeId>pm_12814_24_23492645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D9935A3-66CE-4B7E-80C7-0743A39F548D</gtr:id><gtr:title>Prevalence and markers of advanced liver disease in type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ad0505b5e34cb9c9e0ef28546bcbf33"><gtr:id>3ad0505b5e34cb9c9e0ef28546bcbf33</gtr:id><gtr:otherNames>Williamson RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>pm_12814_24_22156706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0748AFD8-3CB4-4924-9AAD-2385846C24A5</gtr:id><gtr:title>Genetic variants associated with altered plasma levels of C-reactive protein are not associated with late-life cognitive ability in four Scottish samples.</gtr:title><gtr:parentPublicationTitle>Behavior genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92c807dd74c086f13d2174d70fc9bf1c"><gtr:id>92c807dd74c086f13d2174d70fc9bf1c</gtr:id><gtr:otherNames>Marioni RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-8244</gtr:issn><gtr:outcomeId>ZeCYMRyQk56</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1C53DA9-2785-45C8-9813-C02372CDCD33</gtr:id><gtr:title>Genome wide association identifies common variants at the SERPINA6/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c4e993e4fbbfa502e8e4bb3de0304b0"><gtr:id>6c4e993e4fbbfa502e8e4bb3de0304b0</gtr:id><gtr:otherNames>Bolton JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_12814_24_25010111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F19CC8EA-01F2-4B1D-BADF-7665B521E947</gtr:id><gtr:title>Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a2c6bfb5da80ddad2573276d31f7e7b"><gtr:id>0a2c6bfb5da80ddad2573276d31f7e7b</gtr:id><gtr:otherNames>N?esch E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>555d9688d521f0.61006764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C77A6F78-540F-4FA8-BB97-172C75EEA6B7</gtr:id><gtr:title>The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ad756a05d24b86ee8a1edc56a7012aa"><gtr:id>4ad756a05d24b86ee8a1edc56a7012aa</gtr:id><gtr:otherNames>Feinkohl I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>55a382fdc94e40.37351840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD59BB07-FE08-4874-9605-C57A47C80B49</gtr:id><gtr:title>Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9af579e58c96e7ec539350c53d976d5b"><gtr:id>9af579e58c96e7ec539350c53d976d5b</gtr:id><gtr:otherNames>Inkster B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>pm_12814_24_24089545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B20F9DD-3CF8-4526-8DCC-CDD25687036F</gtr:id><gtr:title>Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/494ba6196af3cd99ac66b5a0659118db"><gtr:id>494ba6196af3cd99ac66b5a0659118db</gtr:id><gtr:otherNames>Ding J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>bGbUzA9vKXP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3D169C9-E273-440B-8C06-8ABCFBED22CD</gtr:id><gtr:title>Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee011dfb51cc6b6d114a37b44f1ec757"><gtr:id>ee011dfb51cc6b6d114a37b44f1ec757</gtr:id><gtr:otherNames>Labad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>714C2D7742F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CFE587E-3879-42B2-B7E3-93EE3CD0788D</gtr:id><gtr:title>Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetic medicine : a journal of the British Diabetic Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54822259648acbae4daf358f01b21843"><gtr:id>54822259648acbae4daf358f01b21843</gtr:id><gtr:otherNames>Jenks SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn><gtr:outcomeId>pm_12814_24_24684407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD98FB46-4890-4548-8C30-CEED880EC467</gtr:id><gtr:title>Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c7061aeaf918c581ecd8b4424e6f09e"><gtr:id>5c7061aeaf918c581ecd8b4424e6f09e</gtr:id><gtr:otherNames>Betz BB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>57174f736ac254.57870971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A05B3010-0397-447B-8C9B-2D609A97961C</gtr:id><gtr:title>Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92c807dd74c086f13d2174d70fc9bf1c"><gtr:id>92c807dd74c086f13d2174d70fc9bf1c</gtr:id><gtr:otherNames>Marioni RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>cvsKm6oafq9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3FE0078-1E93-4B29-8674-795DD49E1244</gtr:id><gtr:title>Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetic medicine : a journal of the British Diabetic Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85083d96d7bc4d7f462a1e9c6647c5e3"><gtr:id>85083d96d7bc4d7f462a1e9c6647c5e3</gtr:id><gtr:otherNames>Aung PP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn><gtr:outcomeId>RYLCLcxMnKb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4532E043-28E1-4F73-872A-9CCD7F1E057F</gtr:id><gtr:title>Prevalence of abnormal plasma liver enzymes in older people with Type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetic medicine : a journal of the British Diabetic Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5161c8803a66c22f1413fddae8ebae98"><gtr:id>5161c8803a66c22f1413fddae8ebae98</gtr:id><gtr:otherNames>Morling JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn><gtr:outcomeId>PzM2un6dhmp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CD7E797-F8D3-427C-BC0C-4999C64FB21E</gtr:id><gtr:title>Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0b0d894ef807f1af6ae0b393015d3fe"><gtr:id>b0b0d894ef807f1af6ae0b393015d3fe</gtr:id><gtr:otherNames>Price AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>5a73285907e2e4.63451529</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500877</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>